Center of Molecular Biology and Pharmacogenetics


Research Lines


Genetic and Epigenetics Basis of Priority Diseases: the objective is to identify genetic and epigenetics variants related to the development of major vascular and metabolic diseases that affect our country, such as venous thrombosis, coronary artery disease, restenosis, diabetes mellitus, obesity and polycystic ovary syndrome. Responsible: Dr. Luis Salazar.


Cardiovascular Pharmacogenetics and Pharmacoepigenetics: investigates the effect of genetic and epigenetic variants on the therapeutic response to anticoagulant, hypoglycemic and hypolipidemic drugs with the aim of identifying molecular biomarkers to predict response to treatment or susceptibility to adverse drug reactions, and identification of new therapeutic targets. Responsible: Dr. Luis Salazar.


Identification of Active Principles of Native Plants with Therapeutic Action: the main aim is the detection and identification of active ingredients with antibacterial and antifungal action on pathogens that affect the oral cavity. It also investigates the potential anti-inflammatory, hypoglycemic, antiangiogenic and antiatherogenic activity of active principles isolated from natural products. Responsible: Dr. Luis Salazar.


Biotechnological Applications of Antarctic Bioresources: the main aim is the detection and identification of active metabolites with potential applications on chemical and food industry, pharmacology and health. Responsible: Dr. Leticia Barrientos.